Results for "Understanding Pharmaceutical Distribution"
HDA Statement on FDA’s Phased Exemption for Eligible Trading Partners from the DSCSA’s Final Implementation Requirements
HDA released a statement from President and CEO Chester “Chip” Davis, Jr., on the Food and Drug Administration’s (FDA) issuing of an exemption for eligible trading partners to comply with the final requirements of the Drug Supply Chain Security Act (DSCSA).
HDA To Host Traceability Seminar in August
The Healthcare Distribution Alliance (HDA) will host its annual Traceability Seminar two months early, on August 29–31, 2023, in Washington, D.C. The earlier date reflects the urgency surrounding the upcoming Drug Supply Chain Security Act (DSCSA) implementation deadline and the critical need to share information and solutions.